News
The stock's rise snapped a three-day losing streak.
Zacks Investment Research on MSN6h
Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact?Women’s health medical device maker, Hologic HOLX, is struggling with continued softness in its core Breast Health segment. Sales fell 6.2% in the fiscal 2025 second quarter due to weaker sales of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback